• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dow subsidiary presents transdermal delivery system

November 10, 2016 By Sarah Faulkner

Dow subsidiary presents transdermal delivery systemDow (NYSE:DOW) subsidiary Dow Corning presented its latest drug delivery tech for transdermal therapies at the American Assn. of Pharmaceutical Sciences annual meeting.

Dow Corning introduced its transdermal delivery patch, the SilAc Hybrid pressure-sensitive adhesive, which combine the properties of acrylic and silicone polymers. The Midland, Mich.-based company also featured its silicone-based topical ingredients with enhanced spreading capabilities and sensory properties so its customers can develop novel formulations for acne management.

“Transdermal and topical drug delivery systems must ensure proper drug loading, stability and release,” strategic marketing director for healthcare Gary Lord said in prepared remarks. “Dow Corning supports evolving industry requirements by continuing to expand our silicone-based solutions for drug delivery and consumer healthcare applications. We have enhanced our BIO-PSA family with a single-technology hybrid solution that addresses multiple needs for patch formulators and pharmaceutical companies. Also, we are offering formulators new concepts for the growing market in OTC acne management. Through innovation and collaboration, Dow Corning is helping the industry achieve its current and future goals.”

Dow Pharma Solutions showcased a number of compounds designed to enhance solubility and productivity of pharmaceuticals, such as the Ethocel High Productivity polymers used for high-speed dry powder layering processes and the Methocel DC2 for dry powder processing.

For 73 years, Dow Corning was a joint venture between Dow and Corning. In June 2016, Dow became 100% owner of Dow Corning’s silicones business.

“Separately, Dow and Dow Corning were experts in drug delivery, but coming together truly deepens, broadens and strengthens our expertise,” Dow Pharma Solutions global marketing leader Dago Caceres added. “Strong synergies between our 2 organizations provide access to expanded resources, services and technologies, including additional research and development capabilities.”

Filed Under: Business/Financial News, Featured, Pharmaceuticals Tagged With: Dow Corning

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS